Redefining Surgical Indications in Type 2 Diabetes: A Metabolic-Stage–Driven Approach in Non-Obese Populations
International Science Journal · 2025
DOI: 10.64784/083 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Science Journal, 2025. Verfasst von Rafael Rodríguez Ornelas und 7 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM) in non-obese individuals represents a growing clinical challenge, particularly in regions where metabolic risk is not adequately captured by body mass index alone. In recent years, metabolic surgery has gained attention as a potential therapeutic option for selected non-obese patients, based on evidence suggesting that its benefits extend beyond weight reduction and involve sustained endocrine modulation. This narrative review analyzes the evolving role of metabolic surgery in non-obese patients with T2DM, focusing on emerging selection criteria and reported endocrine outcomes. The review synthesizes international literature and conceptual frameworks of chronic disease management to identify consistent patterns in patient selection, underlying physiological mechanisms, and clinically relevant outcomes. Across the reviewed evidence, selection criteria increasingly prioritize beta-cell reserve, disease duration, metabolic phenotype, and glycemic refractoriness over anthropometric thresholds. Reported outcomes predominantly emphasize sustained glycemic control, reduction in pharmacologic treatment burden, and improvements in insulin sensitivity, while remission is described as a variable outcome dependent on baseline metabolic capacity and follow-up duration. The findings support the interpretation of metabolic surgery as a durable endocrine-modifying intervention that requires careful patient selection and structured long-term follow-up. This perspective is particularly relevant for Latin American healthcare systems, including those in Mexico, Colombia, and Ecuador, where chronic disease management is influenced by system-level factors such as continuity of care and access to multidisciplinary monitoring.
Zitieren
APA
Ornelas, R. R., Arquieta, R. A. F., Vásquez, B. A. R., Garcia, M. N. E., Prado, L. O. N., Cazares, H. E. A., Guillin, W. R. C., & González, R. A. L. (2025). Redefining Surgical Indications in Type 2 Diabetes: A Metabolic-Stage–Driven Approach in Non-Obese Populations. International Science Journal. https://doi.org/10.64784/083
Vancouver
Ornelas RR, Arquieta RAF, Vásquez BAR, Garcia MNE, Prado LON, Cazares HEA, et al. Redefining Surgical Indications in Type 2 Diabetes: A Metabolic-Stage–Driven Approach in Non-Obese Populations. International Science Journal. 2025. doi:10.64784/083
BibTeX
@article{Ornelas2025,
author = {Ornelas, Rafael Rodríguez and Arquieta, Rogelio Alejandro Flores and Vásquez, Bryan Andrés Ramírez and Garcia, Mayra Nayeli Estrada and Prado, Lenin Omar Nevárez and Cazares, Hector Eliud Arriaga and Guillin, Wilmer Rene Cujilema and González, Rogelio Adrián Llanes},
title = {Redefining Surgical Indications in Type 2 Diabetes: A Metabolic-Stage–Driven Approach in Non-Obese Populations},
journal = {International Science Journal},
year = {2025},
doi = {10.64784/083}
}
EUVIMED